Emerging & rare fungal infections in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Kubak, B M ^a   Huprikar, S S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Emerging fungal pathogens; Hyalohyphomycosis; Phaeohyphomycosis; Zygomycosis

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; CLOTRIMAZOLE; CORTICOSTEROID; ECHINOCANDIN; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRISEOFULVIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POSACONAZOLE; RAVUCONAZOLE; TACROLIMUS; TERBINAFINE; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VORICONAZOLE;

ADD ON THERAPY; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONIDIOBOLUS; DEBRIDEMENT; DERMATOMYCOSIS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; FUNGAL COLONIZATION; FUNGUS TRANSMISSION; FUSARIOSIS; GEOGRAPHY; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HYALOHYPHOMYCOSIS; KERATITIS; LUNG INFECTION; MORTALITY; MOULD; MUCORMYCOSIS; MYCOSIS; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; ORGAN DONOR; ORGAN TRANSPLANTATION; OXYGEN THERAPY; PATHOGENESIS; PENICILLIOSIS; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; REVIEW; RISK FACTOR; SCEDOSPORIUM; SEROLOGY; SOLID ORGAN TRANSPLANTATION; SOUTH AMERICAN BLASTOMYCOSIS; SPOROTRICHOSIS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TRICHOSPORONOSIS; YEAST; ZYGOMYCETES;

ANTIFUNGAL AGENTS; HUMANS; MYCOSES; OCCUPATIONAL EXPOSURE; ORGAN TRANSPLANTATION; TISSUE DONORS;

EID: 72949091077     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02913.x     Document Type: Review

References (104)

1. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005 17 : 89 92.
2. Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs 2007 67 : 1803 1812.
3. Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008 14 (Suppl 4 5 24.
4. Kubak BM, Pegues DA, Holt CD, Hwang AH. Changing patterns of fungal infection in transplantation. Curr Opin Organ Transplant 2000 5 : 176 191.
5. Varkey JB, Perfect JR. Rare and emerging fungal pulmonary infections. Semin Respir Crit Care Med 2008 29 : 121 131.
6. Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007 139 : 519 531.
7. Stelzmueller I, Lass-Floerl C, Geltner C et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int 2008 21 : 534 546.
8. Husain S, Alexander BD, Munoz P et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003 37 : 221 229.
9. Fungal infections. Am J Transplant 2004 4 (Suppl 10 110 134.
10. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000 70 : 112 116.
11. Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis 2001 3 : 128 137.
12. Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002 16 : 915 933, vi-vii.
13. Sole A, Salavert M. Fungal infections after lung transplantation. Transplant Rev (Orlando) 2008 22 : 89 104.
14. Symoens F, Knoop C, Schrooyen M et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006 25 : 603 607.
15. Gauwerky K, Borelli C, Korting HC. Targeting virulence: A new paradigm for antifungals. Drug Discov Today 2009.
16. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006 20 : 581 607, vi.
17. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004 39 : 584 587.
18. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004 350 : 950 952.
19. Murray PR, American Society for Microbiology. Manual of clinical microbiology. 7th ed. Washington, D.C. : ASM Press, 1999.
20. Crissey JT, Lang H, Parish LC. Manual of medical mycology. Cambridge, Mass, USA : Blackwell Scientific, 1995.
21. Patterson TF. Advances and challenges in management of invasive mycoses. Lancet 2005 366 : 1013 1025.
22. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009 47 : 3 15.
23. Logan PM, Primack SL, Miller RR, Muller NL. Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. Radiology 1994 193 : 383 388.
24. Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000 19 : 53 56.
25. Kanj SS, Welty-Wolf K, Madden J et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) 1996 75 : 142 156.
26. Nunley DR, Gal AA, Vega JD, Perlino C, Smith P, Lawrence EC. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002 122 : 1185 1191.
27. Paradowski LJ. Saprophytic fungal infections and lung transplantation-revisited. J Heart Lung Transplant 1997 16 : 524 531.
28. Silveira FP, Kwak EJ, Paterson DL, Pilewski JM, McCurry KR, Husain S. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008 27 : 850 855.
29. Sahi H, Avery RK, Minai OA et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007 26 : 350 356.
30. Rubin RH, Young LS. Clinical approach to infection in the compromised host. 4th ed. New York : Kluwer Academic/Plenum, 2002.
31. Gill J, Madhira BR, Gjertson D et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 2008 3 : 1820 1828.
32. Wuyts WA, Molzahn H, Maertens J et al. Fatal Scopulariopsis infection in a lung transplant recipient: a case report. J Heart Lung Transplant 2005 24 : 2301 2304.
33. Castelli MV, Buitrago MJ, Bernal-Martinez L, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J Clin Microbiol 2008 46 : 3412 3416.
34. Spiess B, Seifarth W, Hummel M et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007 45 : 3743 3753.
35. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006 6 : 2365 2374.
36. Abbott KC, Hypolite I, Poropatich RK et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001 3 : 203 211. (Pubitemid 34051921)
37. Einollahi B, Taheri S. Renal transplantation practice in Iran and the Middle East: report from Iran and a review of the literature. Ann Transplant 2008 13 : 5 14.
38. Jimenez C, Lumbreras C, Paseiro G et al. Treatment of mucor infection after liver or pancreas-kidney transplantation. Transplant Proc 2002 34 : 82 83. (Pubitemid 34311580)
39. Dubey A, Patwardhan RV, Sampth S, Santosh V, Kolluri S, Nanda A. Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol 2005 63 : 254 260 discussion 260.
40. Uckay I, Chalandon Y, Sartoretti P et al. Invasive zygomycosis in transplant recipients. Clin Transplant 2007 21 : 577 582.
41. Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008 10 : 419 425.
42. McGuire FR, Grinnan DC, Robbins M. Mucormycosis of the bronchial anastomosis: a case of successful medical treatment and historic review. J Heart Lung Transplant 2007 26 : 857 861.
43. Forrest GN, Mankes K. Outcomes of invasive zygomycosis infections in renal transplant recipients. Transpl Infect Dis 2007 9 : 161 164.
44. Marks WH, Florence L, Lieberman J et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996 61 : 1771 1774.
45. Mattner F, Weissbrodt H, Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004 36 : 312 314.
46. Husain S, Munoz P, Forrest G et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005 40 : 89 99.
47. Rodriguez-Tudela JL, Berenguer J, Guarro J et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2008 : 1 12.
48. Musk M, Chambers D, Chin W, Murray R, Gabbay E. Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant 2006 25 : 1268 1272.
49. Farina C, Gotti E, Suter F, Goglio A. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature. Transplant Proc 2006 38 : 1333 1335.
50. Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005 139 : 370 373.
51. Rogasi PG, Zanazzi M, Nocentini J et al. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Transplant Proc 2007 39 : 2033 2035.
52. Ahmed J, Ditmars DM, Sheppard T, del Busto R, Venkat KK, Parasuraman R. Recurrence of Scedosporium apiospermum infection following renal re-transplantation. Am J Transplant 2004 4 : 1720 1724.
53. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987 106 : 209 216.
54. Brown RS Jr., Lake JR, Katzman BA et al. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation 1996 61 : 666 669.
55. Schell WA. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med 1995 15 : 365 387.
56. Kibbler CC. Infections in liver transplantation: risk factors and strategies for prevention. J Hosp Infect 1995 30 (Suppl 209 217.
57. Goldfarb NS, Avery RK, Goormastic M et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001 71 : 242 246.
58. Kriett JM, Smith CM, Hayden AM et al. Lung transplantation without the use of antilymphocyte antibody preparations. J Heart Lung Transplant 1993 12 (6 Pt 1 915 922 discussion 922-913.
59. Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006 12 : 948 960.
60. Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008 10 : 117 122.
61. Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002 35 : 1360 1367.
62. De Miguel D, Gomez P, Gonzalez R et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005 53 : 33 37.
63. Bowden RA, Ljungman P, Paya CV. Transplant infections. 2nd ed. Philadelphia : Lippincott Williams & Wilkins, 2003.
64. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999 1 : 247 261.
65. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997 24 : 369 374.
66. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001 71 : 910 913.
67. McCown HF, Sahn EE. Subcutaneous phaeohyphomycosis and nocardiosis in a kidney transplant patient. J Am Acad Dermatol 1997 36 (5 Pt 2 863 866.
68. Parra IH, Galimberti R, Galimberti G, Guanella B, Kowalczuk A. Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient. Int J Dermatol 2008 47 : 571 574.
69. Sartoris KE, Baillie GM, Tiernan R, Rajagopalan PR. Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: case report and review of the literature. Pharmacotherapy 1999 19 : 995 1001.
70. Calabro G, Nino M, Gallo L, Scalvenzi M. Cutaneous alternariosis in a kidney transplantation recipient: report of a case. J Dermatolog Treat 2008 19 : 246 248.
71. Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002 3 : 19 35.
72. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993 16 : 677 688.
73. Lussier N, Laverdiere M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis 2000 31 : 1299 1301.
74. Netsvyetayeva I, Swoboda-Kopec E, Sikora M, Jaworska-Zaremba M, Blachnio S, Luczak M. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses 2008.
75. Ness MJ, Markin RS, Wood RP, Shaw BW Jr., Woods GL. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol 1989 92 : 119 123.
76. Finkelstein R, Singer P, Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med 1989 86 : 133.
77. Abdala E, Lopes RI, Chaves CN, Heins-Vaccari EM, Shikanai-Yasuda MA. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl Infect Dis 2005 7 : 162 165.
78. Nettles RE, Nichols LS, Bell-McGuinn K, Pipeling MR, Scheel PJ Jr., Merz WG. Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient. Clin Infect Dis 2003 36 : E63 66.
79. Madhavan T, Eisses J, Quinn EL. Infections due to Trichosporon cutaneum, an uncommon systemic pathogen. Henry Ford Hosp Med J 1976 24 : 27 30.
80. Saul SH, Khachatoorian T, Poorsattar A et al. Opportunistic Trichosporon pneumonia. Association with invasive aspergillosis. Arch Pathol Lab Med 1981 105 : 456 459.
81. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983 198 : 622 629.
82. Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006 42 : 753 757.
83. Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 2000 19 : 215 219.
84. Ertam I, Aytimur D, Alper S. Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient. Indian J Dermatol Venereol Leprol 2007 73 : 425 426.
85. Zhao HM, Ran YP, Jiang X et al. [Isolation of Malassezia furfur from the groin abscess of a renal transplant patient]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 36 : 143 146.
86. Alothman A. Rhodotorula species peritonitis in a liver transplant recipient: a case report. Saudi J Kidney Dis Transpl 2006 17 : 47 49.
87. Riedel DJ, Johnson JK, Forrest GN. Rhodotorula glutinis fungemia in a liver-kidney transplant patient. Transpl Infect Dis 2008 10 : 197 200.
88. Gamma R, Carrel T, Schmidli J et al. Transplantation of yeast-infected cardiac allografts: a report of 2 cases. J Heart Lung Transplant 2005 24 : 1159 1162.
89. Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol 2003 41 : 5233 5235.
90. Qadri SM, Al Dayel F, Strampfer MJ, Cunha BA. Urinary tract infection caused by Hansenula anomala. Mycopathologia 1988 104 : 99 101.
91. Wang JL, Hung CC, Chang SC, Chueh SC, La MK. Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B. Transplantation 2003 76 : 1136 1137.
92. Hung CC, Hsueh PR, Chen MY, Hsiao CH, Chang SC, Luh KT. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis 1998 26 : 202 203.
93. Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc 1999 50 : 111 114.
94. Chan YH, Wong KM, Lee KC et al. Pneumonia and mesenteric lymphadenopathy caused by disseminated Penicillium marneffei infection in a cadaveric renal transplant recipient. Transpl Infect Dis 2004 6 : 28 32.
95. Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis 1984 129 : 340 342.
96. Shikanai-Yasuda MA, Duarte MI, Nunes DF et al. Paracoccidioidomycosis in a renal transplant recipient. J Med Vet Mycol 1995 33 : 411 414.
97. Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop Sao Paulo 2004 46 : 279 281.
98. Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987 9 : 369 375.
99. Tambini R, Farina C, Fiocchi R et al. Possible pathogenic role for Sporothrix cyanescens isolated from a lung lesion in a heart transplant patient. J Med Vet Mycol 1996 34 : 195 198.
100. Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008 61 (Suppl 1 i35 i40.
101. Frampton JE, Scott LJ. Posaconazole: a review of its use in the prophylaxis of invasive fungal infections. Drugs 2008 68 : 993 1016.
102. Stanzani M, Vianelli N, Bandini G et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006 53 : e243 e246.
103. Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005 18 : 613 618.
104. Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother 2006 50 : 2248 2250.